Anju Shrestha
Director Global Patient Safety at Regeneron
- Role
- Director, Global Patient Safety Lead, Heme-oncology at Regeneron
- Location
- Randolph, NJ, US
- LinkedIn followers
- 500 followers
About Anju Shrestha
Experienced pharmacovigilance physician in global pharmaceutical market with extensive background of patient care and clinical research. Demonstrated professional competency with excellent medical knowledge and sound clinical judgment in medical digital environment. Focus on intellectual agility to contribute substantially to drug safety leadership role and become a trusted adviser of multi-function global clinical and medical team. Safety expertise from development to life cycle phase of various medicinal products.Structured Benefit Risk AssessmentRisk Management PlanSignal Detection and AssessmentClinical Trials | Phase I to Phase IVPragmatic Clinical Trial DesignRegistry Based Clinical TrialRegulatory Submission and ResponseMedical PublicationsHigh Performing and Learning Agility
Experience
Director, Global Patient Safety Lead, Heme-oncology
Jun 2022 — Present · NJ, US
Education
Cebu Doctors University
MD, Medicine
Rutgers University–Newark
MS Clinical Trial Science , Drug Safety track
2018
Skills
- Good Clinical Practice (Gcp)
- Regulatory Affairs
- Clinical Development
- Clinical Trials
- Infectious Diseases
- Edc
- Ctms
- Ich-Gcp
- Clinphone
- CRO
- U.s. Food and Drug Administration (Fda)
- Quality Patient Care
- Pharmacovigilance
- Adverse Event Reporting
- Medical Affairs
- Clinical Research
- Vaccines
- Pharmaceutical Industry
- Fda
- Drug Safety
- Epro
- Oncology
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.